CAM
AZN icon

Cypress Asset Management’s AstraZeneca AZN Stock Holding History

Cypress Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,323
Closed -$362K – 106
2024
Q3 		$362K Buy
2,323
+760
+49% +$123K 0.09% 91
2024
Q2 		$253K Buy
+1,563
New +$235K 0.07% 95
2021
Q1 		– Sell
-2,125
Closed -$212K – 139
2020
Q4 		$212K Hold
2,125
– – 0.06% 141
2020
Q3 		$233K Hold
2,125
– – 0.07% 125
2020
Q2 		$225K Buy
+2,125
New +$219K 0.08% 123
2018
Q1 		– Sell
-3,088
Closed -$214K – 177
2017
Q4 		$214K Sell
3,088
-225
-7% -$15.2K 0.05% 178
2017
Q3 		$224K Hold
3,313
– – 0.05% 184
2017
Q2 		$226K Sell
3,313
-2,225
-40% -$145K 0.05% 183
2017
Q1 		$345K Sell
5,538
-1,550
-22% -$90.2K 0.07% 169
2016
Q4 		$387K Sell
7,088
-525
-7% -$29.8K 0.07% 159
2016
Q3 		$500K Sell
7,613
-1,822
-19% -$119K 0.1% 137
2016
Q2 		$570K Sell
9,435
-51,263
-84% -$2.98M 0.11% 137
2016
Q1 		$3.42M Sell
60,698
-1,137
-2% -$68.3K 0.69% 50
2015
Q4 		$4.2M Sell
61,835
-665
-1% -$43.6K 0.84% 38
2015
Q3 		$3.98M Buy
62,500
+95
+0.2% +$6.25K 0.84% 45
2015
Q2 		$3.98M Buy
62,405
+1,095
+2% +$75K 0.75% 46
2015
Q1 		$4.2M Buy
+61,310
New +$4.26M 0.78% 43

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Cypress Asset Management's AZN Position: Q4 2024 in Review

Cypress Asset Management sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 2,323 shares — an estimated $362K sold.

Cypress Asset Management first reported a position in AZN in Q1 2015 and held it in 17 quarters. The position peaked at $4.2M in Q4 2015. 1,219 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

  • Cypress Asset Management reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
  • Cypress Asset Management sold 2,323 AstraZeneca shares in Q4 2024, an estimated $362K.
  • Cypress Asset Management first reported a position in AstraZeneca in Q1 2015 and held it in 17 quarters.
  • Cypress Asset Management's AstraZeneca position peaked at $4.2M in Q4 2015.
  • 1,219 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Cypress Asset Management's 13F filing for Q4 2024, filed 24 Feb 2025.